General LC-MS/MS Method Approach to Quantify Therapeutic Monoclonal Antibodies Using a Common Whole Antibody Internal Standard with Application to Preclinical Studies
- 5 January 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 84 (3), 1267-1273
- https://doi.org/10.1021/ac202792n
Abstract
Ligand binding assays (LBAs) are widely used for therapeutic monoclonal antibody (mAb) quantification in biological samples. Major limitations are long method development times, reagent procurement, and matrix effects. LC-MS/MS methods using signature peptides are emerging as an alternative approach, which typically use a stable isotope labeled signature peptide as the internal standard (IS). However, a new IS has to be generated for every candidate, and the IS may not correct for variations at all processing steps. We have developed a general LC-MS/MS method approach employing a uniformly heavy-isotope labeled common whole mAb IS and a common immunocapture for sample processing. The method was streamlined with automation for consistency and throughput. Method qualification of four IgG2 and four IgG1 mAbs showed sensitivity of 0.1 μg/mL and linearity of 0.1–15 μg/mL. Quality control (QC) data of these eight mAbs were accurate and precise. The QC performance of the whole molecule labeled IS was better than those of synthetic labeled IS peptides tested. The pharmacokinetic results of two mAbs (an IgG2 and IgG1 candidate) dosed in rats were comparable to those of LBA. The general LC-MS/MS method approach overcomes the limitations of current methods to reduce time and resources required for preclinical studies.This publication has 19 references indexed in Scilit:
- Quantitation of a recombinant monoclonal antibody in monkey serum by liquid chromatography–mass spectrometryAnalytical Biochemistry, 2011
- Bioanalysis of recombinant proteins and antibodies by mass spectrometryThe Analyst, 2009
- Monoclonal Antibody Pharmacokinetics and PharmacodynamicsClinical Pharmacology & Therapeutics, 2008
- Towards Absolute Quantification of Therapeutic Monoclonal Antibody in Serum by LC−MS/MS Using Isotope-Labeled Antibody Standard and Protein Cleavage Isotope Dilution Mass SpectrometryAnalytical Chemistry, 2008
- Immunopurification and Mass Spectrometric Quantification of the Active Form of a Chimeric Therapeutic Antibody in Human SerumAnalytical Chemistry, 2008
- Absolute Quantification of Monoclonal Antibodies in Biofluids by Liquid Chromatography−Tandem Mass SpectrometryAnalytical Chemistry, 2008
- Immuno‐mass spectrometry assay of EPI‐HNE4, a recombinant protein inhibitor of human elastaseRapid Communications in Mass Spectrometry, 2007
- Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma ProteinsMolecular & Cellular Proteomics, 2006
- Recommendations for the Bioanalytical Method Validation of Ligand-Binding Assays to Support Pharmacokinetic Assessments of MacromoleculesPharmaceutical Research, 2003
- Validation of immunoassays for bioanalysis: a pharmaceutical industry perspectiveJournal of Pharmaceutical and Biomedical Analysis, 1999